In neoplastic contexts, BCR signaling can become constitutively active or antigen‐independent, delivering continuous survival and proliferative signals that support tumor growth, facilitate immune evasion, and contribute to resistance to conventional chemotherapies [10]. The gene discussed is BCR; the disease is neoplasm.